Document is current

Article History

Received: 21 May 2020

Accepted: 4 June 2020

First Online: 15 June 2020

Ethics approval and consent to participate

: N/A

: Yes

: A.D. was supported by the National Institutes for Health grant K23GM129660.R.H. has received no direct financial support, nor does he or his family hold patents or equity interest in any biotech or pharmaceutical company. He has received laboratory research support from the Bristol-Myers Squibb, GlaxoSmithKline, and RevImmune; has served as a paid consultant to the Bristol-Myers Squibb and GlaxoSmithKline; and has received grant support from the US NIH and US Public Health Service for research investigations of sepsis.E.K. has an equity interest in Attune Medical.